HALLMARK FINANCIAL SERVICES INC FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
Item 1.01. Entry Into a Material Definitive Agreement.
The information set forth below in "Item 2.01 Completion of Acquisition or
Disposition of Assets" of this Current Report on Form 8-K is incorporated into
this Item 1.01 by reference.
Item 2.01. Completion of Acquisition or Disposition of Assets.
On
"Sellers"), entered into a Master Transaction Agreement (the "MTA") with
Insurance Holdings, Inc.
Pursuant to the MTA, as of the Effective Date (as defined below), the Company
sold, and Buyer purchased, 100% of the issued and outstanding units of the
Company's agency subsidiary,
assets, and Buyer acquired such assets and assumed certain liabilities, of the
Sellers' excess and surplus lines operations (the "Business"), for total
consideration of
as of the Effective Date, in exchange for the reinsurance by the Reinsurer (as
defined below) of liabilities associated with the unearned premium reserves
under the Reinsurance Agreement (as defined below), the Ceding Companies (as
defined below) delivered to the Reinsurer an amount equal to the net unearned
premium reserve of the Ceding Companies in respect of the Business (estimated to
be
(estimated to be
therefor.
The MTA contains customary representations and warranties with respect to Buyer,
the Sellers and HXS, as well as customary post-closing covenants. Following the
closing of the transactions contemplated by the MTA, the Sellers and Buyer have
agreed to indemnify the other for breaches of representations, warranties,
covenants and certain other matters specified therein. Affiliates of Buyer and
the Sellers also entered into certain other transaction documents in order to
effectuate the transactions contemplated by the MTA.
written opinion to the Board of Directors of the Company as to the fairness,
from a financial point of view, of the consideration received by the Company
pursuant to the MTA as of
In connection with the MTA,
Company
with HSIC, AHIC and HIC, the "Ceding Companies"), each a subsidiary of the
Company, entered into an Unearned Premium and Prospective Quota Share
Reinsurance Agreement (the "Reinsurance Agreement") with
Insurance Company
Reinsurance Agreement, each of the Ceding Companies will cede to Reinsurer, and
Reinsurer will accept and reinsure, on a 100% quota share indemnity reinsurance
basis, unearned premium as of
policies of the Ceding Companies constituting the Business and business placed
by HXS with the Ceding Companies between
2023
the Ceding Companies with respect to such reinsured policies. Certain
transactions contemplated by the MTA and the Reinsurance Agreement are effective
as of
The foregoing descriptions of the MTA, Reinsurance Agreement and transactions
contemplated by such documents do not purport to be complete and are qualified
in their entirety by reference to the full text of (i) the MTA and (ii) the
Reinsurance Agreement. Copies of the MTA and Reinsurance Agreement are filed as
Exhibits 2.1 and 10.1, respectively, and are incorporated herein by reference in
their entirety.
The MTA is not intended to provide any other factual information about the
parties thereto. In particular, the representations and warranties contained in
the MTA were made only for the purposes of the MTA as of specific dates therein
and were solely for the benefit of the parties to the MTA. The representations
and warranties contained in the MTA are subject to limitations agreed upon by
the parties thereto and are qualified by information in confidential disclosure
schedules provided in connection with the signing thereof.
Item 8.01. Other Events.
On
of the transactions contemplated by the MTA and Reinsurance Agreement, a copy of
which is filed as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference in its entirety.
Forward-Looking Statements
This Current Report on Form 8-K contains certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements include statements regarding the intent, belief or current
expectations of the Company and its management team. Investors are cautioned
that any such forward-looking statements speak only as of the date they are
made, are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
which may adversely affect the ability of the Company to realize the anticipated
benefits of the transaction. Important risk factors and information regarding
the Company are described under the heading "Risk Factors" in our Form 10-K
filed with the
15, 2022
on the
on any forward-looking statements, which speak only as of the date hereof. We do
not undertake any duty to update any forward-looking statement or other
information in this Current Report on Form 8-K, except as required by
federal securities law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 2.1 Master Transaction Agreement, dated as ofOctober 7, 2022 , by and amongHallmark Financial Services, Inc. ,Hallmark Specialty Underwriters, Inc. andStarstone U.S. Holdings, Inc. * 10.1 Unearned Premium and Prospective Quota Share Reinsurance Agreement, dated as ofOctober 7, 2022 , by and amongHallmark Specialty Insurance Company ,American Hallmark Insurance Company of Texas ,Hallmark Insurance Company ,Hallmark National Insurance Company and Starstone National Insurance Company . 99.1 Press release, datedOctober 7, 2022 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Schedules have been omitted pursuant to Item 601(a)(5) ofRegulation S-K. Hallmark Financial Services, Inc. agrees to furnish to theSecurities and Exchange Commission a copy of such schedules and exhibits, or any section thereof, upon request.
New Findings from Griffith University in the Area of Autism Reported (Non-pharmacological Interventions for Autistic Children: an Umbrella Review): Developmental Diseases and Conditions – Autism
Researchers Submit Patent Application, “Systems And Methods For Allocating Fault To Autonomous Vehicles”, for Approval (USPTO 20220301069): Patent Application
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News